IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
46,555,827
Share change
+4,176,715
Total reported value
$114,989,251
Put/Call ratio
388%
Price per share
$2.47
Number of holders
80
Value change
+$13,311,778
Number of buys
36
Number of sells
36

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q1 2017

As of 31 Mar 2017, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,555,827 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Broadfin Capital, LLC, FMR LLC, NATIXIS, JPMORGAN CHASE & CO, STATE STREET CORP, NORTHERN TRUST CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 80 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.